诺和诺德（NVO.US）公布2025财年第一财季财报，展现出强劲的发展态势。该季度公司净利润达40.96亿美元，同比增长10.76%；营业收入为110.17亿美元，同比增长15.81% ，每股基本收益0.92美元。从资产负债情况来看，总负债507.65亿美元，其中短期债务32.45亿美元，资产负债比1.40，流动比率0.74 。截至当日，27家机构对其目标价做出预测，目标均价值101.54美元，最低53.90美元，最高139.71美元。诺和诺德作为全球糖尿病护理产品的头部供应商，占据全球约三分之一的品牌糖尿病治疗市场，当前股价表现有一定支撑，未来发展态势值得关注。
| Side | Price | Filled | Realized P&L |
|---|---|---|
| Sell Open | 0.13 2Lot(s) | -- Closed |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- DeltaDrift·2025-07-17强，利润高的LikeReport